The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., has announced a major advancement in oncology with the discovery of PVTX-405, a potent ...

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system ...

Scientists from the Garvan Institute of Medical Research have discovered that certain gene changes linked to leukemia may ...

A Minnesota woman was told her stage 4 colon cancer couldn’t be cured. Two years later, she’s cancer-free — and says a last-chance clinical trial gave her back her life.

What if your body’s own immune system could be taught to wipe out tumours — and do it so effectively that no further ...

May is Melanoma Awareness Month and Intermountain Health is unveiling an exciting new treatment program for Utahns with ...

Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease.

Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting disease.

IO Biotech's first-in-class vaccine performs double duty, killing cancer cells and enhancing the tumor microenvironment. A ...

A drug that is currently used for cancer could be the key in treating a disease that has no cure, and a life expectancy of ...

A cancer drug could help a condition which is incurable and fatal with many of those who have the condition dying within 3 years of diagnosis. Idiopathic Pulmonary Fibrosis, often shortened to IPF, is ...